![Kathy Hibbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathy Hibbs
Direktor/Vorstandsmitglied bei
SOPHIA GENETICS SA
Vermögen: 502 926 $ am 31.05.2026
Profil
Kathy L.
Hibbs is currently an Independent Director at Standard BioTools, Inc. since 2024, a Non-Executive Director at SOPHiA GENETICS SA since 2021, and a Director at Cadex Genomics Corp.
since 2019.
Former roles include Independent Director at SomaLogic, Inc. from 2023 to 2024, Chief Administrative Officer at 23andMe, Inc. from 2022 to 2024, Chief Administrative Officer at Chrome Holding Co. from 2014 to 2024, Secretary, Senior Vice President & General Counsel at Genomic Health, Inc. from 2013 to 2014, Secretary, Senior Vice President & General Counsel at Monogram Biosciences, Inc. from 2001 to 2009, Vice President & General Counsel at Multitude, Inc. from 1994 to 2001, Director-Legal Affairs at Varian Medical Systems, Inc. from 1995 to 1999, and Counsel at Granite Bank, FSB (San Francisco, California).
Also served as Independent Director at Veracyte SD, Inc. Education includes undergraduate studies at the University of California, Riverside and graduate studies at the University of California, Hastings.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SOPHIA GENETICS SA 0.13% | 12.05.2026 | 89’768 ( 0.13% ) | 453 328 $ | 31.05.2026 |
| 15.04.2026 | 43’128 ( 0.01% ) | 49 597 $ | 31.05.2026 |
Aktive Positionen von Kathy Hibbs
| Unternehmen | Position | Beginn |
|---|---|---|
| SOPHIA GENETICS SA | Direktor/Vorstandsmitglied | 01.03.2021 |
| STANDARD BIOTOOLS INC. | Direktor/Vorstandsmitglied | 05.01.2024 |
Cadex Genomics Corp.
 Cadex Genomics Corp. BiotechnologyHealth Technology Develops novel blood-based assays for patients with cancer | Direktor/Vorstandsmitglied | 01.10.2019 |
Ehemalige bekannte Positionen von Kathy Hibbs
| Unternehmen | Position | Ende |
|---|---|---|
| CHROME HOLDING CO. | Verwaltungsdirektor | 24.05.2024 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Verwaltungsdirektor | 01.05.2024 |
| STANDARD BIOTOOLS INC. | Direktor/Vorstandsmitglied | 05.01.2024 |
| GENOMIC HEALTH, INC. | General Counsel | 01.03.2014 |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | General Counsel | 01.10.2009 |
Ausbildung von Kathy Hibbs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies radiotherapy medical devices for treating cancer & develops related software solutions | Health Technology |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
Granite Bank, FSB (San Francisco, California)
 Granite Bank, FSB (San Francisco, California) Savings BanksFinance Federally chartered savings bank | Finance |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Multitude, Inc.
 Multitude, Inc. Packaged SoftwareTechnology Services Provides software and analytic tools that help government and industry leaders transform data from the emergent | Technology Services |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
SOPHiA GENETICS SA
 SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Cadex Genomics Corp.
Cadex Genomics Corp. BiotechnologyHealth Technology Develops novel blood-based assays for patients with cancer | Health Technology |
23andMe Holding Co.
 23andMe Holding Co. BiotechnologyHealth Technology Operates as a genetic testing company | Health Technology |
SomaLogic, Inc.
 SomaLogic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a protein biomarker discovery and clinical diagnostics company | Commercial Services |
